PharmaTher Holdings Ltd. (CSE:PHRM)

Market Cap	11.38M
Revenue (ttm)	n/a
Net Income (ttm)	-1.59M
Shares Out	91.02M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,577
Average Volume	78,089
Open	0.1250
Previous Close	0.1250
Day's Range	0.1150 - 0.1250
52-Week Range	0.1050 - 0.7700
Beta	2.80
RSI	40.85
Earnings Date	Jan 26, 2026

About PharmaTher Holdings

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company’s product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson’s disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia, procedural sedation as well as depression, surgical and pain management. It develops KETARX, a microneedle patch, for mental health, neurological, an...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: PHRM